Alkermes ALKS RISPERDALCONSTA — Number Of License Agreements
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alkermes in its filing.
Tagged under the XBRL concept alks:NumberOfLicenseAgreements.
The official record: Alkermes’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alkermes's risperdalconsta — number of license agreements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alkermes's RISPERDALCONSTA — number of license agreements?
- Alkermes (ALKS) reported RISPERDALCONSTA — number of license agreements of 0.5 in Q4 2025.
- How has Alkermes's RISPERDALCONSTA — number of license agreements changed year-over-year?
- Alkermes's RISPERDALCONSTA — number of license agreements decreased by 0.0% year-over-year, from 0.5 to 0.5.
- What is the long-term trend for Alkermes's RISPERDALCONSTA — number of license agreements?
- Over 4 years (2021 to 2025), Alkermes's RISPERDALCONSTA — number of license agreements has grown at a 0.0% compound annual growth rate (CAGR), from 2 to 2.
- What does RISPERDALCONSTA — number of license agreements mean?
- The total count of active legal contracts under which the company licenses intellectual property or rights related to a specific product or therapeutic segment. This metric reflects the complexity of the product's commercial ecosystem and the reliance on third-party partnerships for distribution or development. A higher number indicates a more fragmented or collaborative commercialization strategy.